MREO
Mereo BioPharma Group Plc
NASDAQ · Healthcare · Biotechnology · GB
$0.29
−4.08%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.01
- Revenue estimate
- $4.6M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.01
- EPS estimate
- -$0.01
- Revenue actual
- —
- Revenue estimate
- $3.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -25.0%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $2.00
- PT range
- $1.00 – $3.00
- Analysts
- 3
2 Buy0 Hold1 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.01 | -$0.01 | In line | — |
| May 12, 2026 | $0.02 | -$0.01 | Miss -150.00% | — |
| Mar 19, 2026 | -$0.01 | -$0.01 | In line | — |
| Mar 26, 2025 | -$0.02 | -$0.01 | Beat 50.00% | $1.3M |
| May 15, 2024 | — | -$0.01 | — | — |
| Nov 17, 2023 | — | -$0.01 | — | $648.8K |
| Sep 7, 2023 | -$0.02 | -$0.03 | Miss -37.05% | $11.1M |
| Nov 2, 2022 | -$0.38 | -$0.02 | Beat 95.58% | $746.8K |
| Jun 30, 2022 | — | -$0.05 | — | — |
| Mar 31, 2022 | — | -$0.03 | — | $606.5K |
| Jun 30, 2021 | — | $0.04 | — | $70.0M |
| Mar 31, 2021 | -$0.07 | -$0.21 | Miss -207.45% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026